These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33652672)

  • 1. Synthesis of Novel Pyrido[1,2-
    Król M; Ślifirski G; Kleps J; Ulenberg S; Belka M; Bączek T; Siwek A; Stachowicz K; Szewczyk B; Nowak G; Duszyńska B; Herold F
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33652672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of new 5,6,7,8-tetrahydropyrido[1,2-c]pyrimidine derivatives with rigidized tryptamine moiety as potential SSRI and 5-HT
    Ślifirski G; Król M; Kleps J; Podsadni P; Belka M; Bączek T; Siwek A; Stachowicz K; Szewczyk B; Nowak G; Bojarski A; Kozioł AE; Turło J; Herold F
    Eur J Med Chem; 2019 Oct; 180():383-397. PubMed ID: 31325785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of novel pyrido[1,2-c]pyrimidine derivatives with rigidized tryptamine moiety as potential SSRI and 5-HT
    Ślifirski G; Król M; Kleps J; Ulenberg S; Belka M; Bączek T; Siwek A; Stachowicz K; Szewczyk B; Nowak G; Bojarski A; Kozioł AE; Turło J; Herold F
    Eur J Med Chem; 2019 Mar; 166():144-158. PubMed ID: 30703658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel 4-aryl-pyrido[1,2-c]pyrimidines with dual SSRI and 5-HT(1A) activity. part 3.
    Herold F; Chodkowski A; Izbicki Ł; Turło J; Dawidowski M; Kleps J; Nowak G; Stachowicz K; Dybała M; Siwek A; Mazurek AP; Mazurek A; Pluciński F
    Eur J Med Chem; 2011 Jan; 46(1):142-9. PubMed ID: 21093118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel 4-aryl-pyrido[1,2-c]pyrimidines with dual SSRI and 5-HT(1A) activity. Part 5.
    Gomółka A; Ciesielska A; Wróbel MZ; Chodkowski A; Kleps J; Dawidowski M; Siwek A; Wolak M; Stachowicz K; Sławińska A; Nowak G; Satała G; Bojarski AJ; Belka M; Ulenberg S; Bączek T; Skowronek P; Turło J; Herold F
    Eur J Med Chem; 2015 Jun; 98():221-36. PubMed ID: 26043160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation.
    Liégeois JF; Deville M; Dilly S; Lamy C; Mangin F; Résimont M; Tarazi FI
    J Med Chem; 2012 Feb; 55(4):1572-82. PubMed ID: 22268448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel 4-aryl-pyrido[1,2-c]pyrimidines with dual SSRI and 5-HT1A activity. Part 4.
    Chodkowski A; Wróbel MZ; Turło J; Kleps J; Siwek A; Nowak G; Belka M; Bączek T; Mazurek AP; Herold F
    Eur J Med Chem; 2015 Jan; 90():21-32. PubMed ID: 25461308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of novel pyrrolidine-2,5-dione derivatives as potential antidepressant agents. Part 1.
    Wróbel MZ; Chodkowski A; Herold F; Gomółka A; Kleps J; Mazurek AP; Pluciński F; Mazurek A; Nowak G; Siwek A; Stachowicz K; Sławińska A; Wolak M; Szewczyk B; Satała G; Bojarski AJ; Turło J
    Eur J Med Chem; 2013 May; 63():484-500. PubMed ID: 23524160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and evaluation of benzo[a]thieno[3,2-g]quinolizines as novel l-SPD derivatives possessing dopamine D1, D2 and serotonin 5-HT1A multiple action profiles.
    Li Z; Huang J; Sun H; Zhou S; Guo L; Zhou Y; Zhen X; Liu H
    Bioorg Med Chem; 2014 Nov; 22(21):5838-46. PubMed ID: 25308766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 6-Acetyl-5-hydroxy-4,7-dimethylcoumarin derivatives: Design, synthesis, modeling studies, 5-HT
    Ostrowska K; Leśniak A; Karczyńska U; Jeleniewicz P; Głuch-Lutwin M; Mordyl B; Siwek A; Trzaskowski B; Sacharczuk M; Bujalska-Zadrożny M
    Bioorg Chem; 2020 Jul; 100():103912. PubMed ID: 32388437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of new hexahydro- and octahydropyrido[1,2-c]pyrimidine derivatives with an arylpiperazine moiety as ligands for 5-HT1A and 5-HT2A receptors. Part 4.
    Herold F; Król M; Kleps J; Nowak G
    Eur J Med Chem; 2006 Jan; 41(1):125-34. PubMed ID: 16263195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of novel 3-(5-substituted-1H-indol-3-yl)pyrrolidine-2,5-dione derivatives with a dual affinity for serotonin 5-HT
    Wróbel MZ; Chodkowski A; Dawidowski M; Siwek A; Stachowicz K; Szewczyk B; Nowak G; Satała G; Bojarski AJ; Turło J
    Bioorg Chem; 2023 Dec; 141():106903. PubMed ID: 37827015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New arylpiperazinylalkyl derivatives of 8-alkoxy-purine-2,6-dione and dihydro[1,3]oxazolo[2,3-f]purinedione targeting the serotonin 5-HT1A /5-HT2A /5-HT7 and dopamine D2 receptors.
    Chłoń-Rzepa G; Zagórska A; Bucki A; Kołaczkowski M; Pawłowski M; Satała G; Bojarski AJ; Partyka A; Wesołowska A; Pękala E; Słoczyńska K
    Arch Pharm (Weinheim); 2015 Apr; 348(4):242-53. PubMed ID: 25773907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New dual 5-HT1A and 5-HT7 receptor ligands derived from SYA16263.
    Ofori E; Onyameh EK; Gonela UM; Voshavar C; Bricker B; Swanson TL; Eshleman AJ; Schmachtenberg JL; Bloom SH; Janowsky AJ; Ablordeppey SY
    Eur J Med Chem; 2021 Mar; 214():113243. PubMed ID: 33582388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel 4-aryl-pyrido[1,2-c]pyrimidines with dual SSRI and 5-HT1A activity, part 1.
    Herold F; Chodkowski A; Izbicki Ł; Król M; Kleps J; Turło J; Nowak G; Stachowicz K; Dybała M; Siwek A
    Eur J Med Chem; 2009 Apr; 44(4):1710-7. PubMed ID: 18995929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological investigation of new equatorial (β) stereoisomers of 3-aminotropane arylamides with atypical antipsychotic profile.
    Stefanowicz J; Słowiński T; Wróbel MZ; Herold F; Gomółka AE; Wesołowska A; Jastrzębska-Więsek M; Partyka A; Andres-Mach M; Czuczwar SJ; Łuszczki JJ; Zagaja M; Siwek A; Nowak G; Żołnierek M; Bączek T; Ulenberg S; Belka M; Turło J
    Bioorg Med Chem; 2016 Sep; 24(18):3994-4007. PubMed ID: 27377863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, biological evaluation, and docking studies of tetrahydrofuran- cyclopentanone- and cyclopentanol-based ligands acting at adrenergic α₁- and serotonine 5-HT1A receptors.
    Prandi A; Franchini S; Manasieva LI; Fossa P; Cichero E; Marucci G; Buccioni M; Cilia A; Pirona L; Brasili L
    J Med Chem; 2012 Jan; 55(1):23-36. PubMed ID: 22145629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New 8-aminoalkyl derivatives of purine-2,6-dione with arylalkyl, allyl or propynyl substituents in position 7, their 5-HT1A, 5-HT2A, and 5-HT7 receptor affinity and pharmacological evaluation.
    Chłoń-Rzepa G; Zmudzki P; Satała G; Duszyńska B; Partyka A; Wróbel D; Jastrzębska-Więsek M; Wesołowska A; Bojarski AJ; Pawłowski M; Zajdel P
    Pharmacol Rep; 2013; 65(1):15-29. PubMed ID: 23563020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of new hexahydro- and octahydropyrido[1,2-c]pyrimidine derivatives with an arylpiperazine moiety as ligands for 5-HT1A and 5-HT2A receptors. Part III.
    Herold F; Król M; Kleps J
    Acta Pol Pharm; 2004; 61(2):139-50. PubMed ID: 15493297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of new multi-target 3-(1H-indol-3-yl)pyrrolidine-2,5-dione derivatives with potential antidepressant effect.
    Wróbel MZ; Chodkowski A; Herold F; Marciniak M; Dawidowski M; Siwek A; Starowicz G; Stachowicz K; Szewczyk B; Nowak G; Belka M; Bączek T; Satała G; Bojarski AJ; Turło J
    Eur J Med Chem; 2019 Dec; 183():111736. PubMed ID: 31586817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.